Aortofemoral bypass in young patients with premature atherosclerosis: is superficial femoral vein superior to Dacron?

Jackson, Mark R.; Ali, Ahsan T.; Bell, Christopher L.; Modrall, J. Gregory; Welborn, M. Burress; Scoggins, Eva; Valentine, R. James; D'Addio, Victor; Clagett, G. Patrick

doi:10.1016/j.jvs.2004.04.002

Cited by 26 publications

(10 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clagett et al, 1 in a series of 41 patients, emphasized the excellent long-term patency of the FV graft with a cumulative patency rate of 100% at 5 years. Jackson et al, 3 graft to Dacron graft in aortofemoral bypasses in patients younger than 55 years treated for aortoiliac occlusive disease, with a patency rate at 5 years of 100% vs 50%, respectively. On the basis of these results, the authors recommended that use of FV as arterial conduit may be considered in young patients.…”

Section: Discussionmentioning

confidence: 99%

Early aneurysmal degeneration of femoral vein conduit used for aortoiliac reconstruction in a child

Bouziane

Settembre

Malikov

2016

Journal of Vascular Surgery Cases, Innovations and Techniques

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Early aneurysmal degeneration of femoral vein conduit used for aortoiliac reconstruction in a child

Bouziane

Settembre

Malikov

2016

Journal of Vascular Surgery Cases, Innovations and Techniques

View full text Add to dashboard Cite

show abstract

“…Use of prosthetic in this patient population has a low primary patency; however, the use of deep vein as conduit results in significantly better 5-year patency rate, with nearly 90% limb salvage. 9 Several factors have been associated with aortobifemoral bypass failures, including young age, virulent aortic disease, small aortic size (such as in women), and progressive infrainguinal disease. 10,11 Patients with these factors have lower primary and secondary patency rates at 5 years, with primary patency rates as low as 66% in patients aged <50 years reported.…”

Section: Discussionmentioning

confidence: 99%

Management of noninfected prosthetic aortic bypass failures using femoral vein

McKeever

Escobar

Moursi

et al. 2016

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…hypercoaguable syndrome). Our series used prosthetic graft for all ABF operations, however Jackson and colleagues 27 have demonstrated that autogenous femoral-popliteal vein may be superior in patients with premature atherosclerotic disease(e.g. age <55).…”

Section: Discussionmentioning

confidence: 99%

Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease

Scali

Schmit

Feezor

et al. 2014

Journal of Vascular Surgery

View full text Add to dashboard Cite

Objective Patients presenting with occluded aortobifemoral bypass(ABF) grafts are managed with a variety of techniques. Redo ABF(rABF) procedures are infrequently performed due to concerns about procedural complexity and morbidity. The purpose of this analysis is to compare mid-term results of rABF to primary ABF(pABF) for aortoiliac occlusive disease(AIOD) to determine if there are significant differences in outcomes. Methods A retrospective review was performed of all patients undergoing ABF for occlusive disease between January 2002 and March 2012. A total of 19 patients underwent rABF and 194 received pABF during that time period. Data for an indication and comorbidity-matched case control cohort of 19 elective pABF patients were collected for comparison to the rABF group. Primary end-points included rate of major complications, as well as 30-day and all-cause mortality. Secondary end-points were amputation-free survival(AFS) and freedom from major adverse limb events(MALEs). Results rABF patients more frequently underwent prior extra-anatomic or lower extremity bypass operations compared to pABF(P=.02), however no difference was found in the incidence of in prior failed endovascular iliac intervention(P =.4). By design, indications for the rABF and pABF groups were the same: claudication, N=6/6(31.6%), P =1; critical limb ischemia, N=13/13(78.4%), P=1. Aortic access was more frequently via retroperitoneal exposure in the rABF group(N=13 vs. N=1;P<.0001) and a significantly higher proportion of the rABF patients required concomitant infrainguinal bypass or intra-procedural adjuncts such profundaplasty(N=14 vs. N=5; P=.01). rABF patients experienced greater blood loss (1097±983mL vs. 580±457mL;P=.02), received more intraoperative fluids(3400±1422mL vs. 2279±993mL;P=.01), and had longer overall procedure times(408±102 vs. 270±48 minutes; P<.0001). Length of stay(days±SD) was similar (pABF, 11.2±10.4 vs. rABF, 9.1±4.5;P=.7) and no 30-day or in-hospital deaths occurred in either group. Similar rates of major complications occurred in the 2 groups(pABF, N=6(31.6%) vs. rABF, N=4(21.1%); observed difference 9.5%, 95% confidence interval:-17.6%, 36.7%;P=.7). Two-year freedom from MALE(±standard error mean) was 82±9% vs. 78±10% for pABF and rABF patients(log-rank, P=.6). Two-year AFS was 90±9% vs. 89±8% between pABF and rABF patients(P=.5). Two-year survival was 91±9% and 90±9% for pABF and rABF patients(P=.8). Conclusions Patients undergoing rABF have higher procedural complexity compared to pABF as evidenced by greater operative time, blood loss and need for adjunctive procedures. However, similar perioperative morbidity, mortality and mid-term survival occurred in comparison to pABF patients. These results support a role for rABF in selected patients.

show abstract

Aortofemoral bypass in young patients with premature atherosclerosis: is superficial femoral vein superior to Dacron?

Abstract: AFB performed with SFV grafts is a far more durable operation than standard D-AFB in young patients with aortoiliac occlusive disease. However, V-AFB is far more likely to require lower extremity fasciotomy, and takes almost twice as long to perform.

Cited by 26 publications

References 11 publications

Early aneurysmal degeneration of femoral vein conduit used for aortoiliac reconstruction in a child

Early aneurysmal degeneration of femoral vein conduit used for aortoiliac reconstruction in a child

Management of noninfected prosthetic aortic bypass failures using femoral vein

Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease

Contact Info

Product

Resources

About